Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County
- PMID: 32738095
- DOI: 10.1111/jrh.12503
Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County
Abstract
Purpose: To evaluate community attitudes concerning opioid use disorder (OUD) and medication for opioid use disorder (MOUD) in a rural community, and to plan educational initiatives to reduce stigma surrounding OUD and treatment.
Methods: Dissemination of a 24-question survey to people living in a rural community followed by comparative analysis of survey results between 2 groups classified by recognition of OUD as a real illness.
Findings: Three hundred sixty-one individuals responded. Overall, 69% agreed that OUD is a real illness. Respondents recognizing OUD as a real illness were less likely to agree that individuals with OUD are dangerous (P = .014), more likely to agree that MOUD is effective (P < .001), that individuals with OUD should have the same right to a job (P < .001), and that naloxone should be administered for every overdose every time (P = .002).
Conclusions: Significant stigma exists toward individuals with OUD in rural communities, and recognizing OUD as a real illness is associated with less stigmatizing attitudes and better understanding of MOUD. Further study should focus on how to effectively convince communities that OUD is a real illness.
Keywords: medication for opioid use disorder; opioid response; opioid use disorder; rural; stigma.
© 2020 National Rural Health Association.
References
-
- Opioid Use Disorder: Challenges and Opportunities in Rural Communities. Philadelphia, PA: The Pew Charitable Trusts; 2020.
-
- Keyes KM, Cerda M, Brady JE, Havens JR, Sandro G. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):52-59.
-
- Dew B, Elifson K, Dozier M. Social and environmental factors and their influence on drug use vulnerability and resiliency in rural populations. J Rural Health. 2007;23:16-21.
-
- Andrilla CHA, Coulthard C, Larson EH. Changes in the Supply of Physicians with a DEA DATA Waiver to Prescribe Buprenorphine for Opioid Use Disorder. Seattle, WA: WWAMI Rural Health Research Center, University of Washington Data Brief #162; 2017.
-
- Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update: distribution of providers with a DEA waiver. J Rural Health. 2019;35(1):108-112.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
